Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Update

Clover Health Investments, Corp. (NASDAQ:CLOV) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 15,080,000 shares, a decline of 8.2% from the January 15th total of 16,420,000 shares. Based on an average daily volume of 6,160,000 shares, the days-to-cover ratio is currently 2.4 days.

Clover Health Investments Price Performance

Shares of NASDAQ CLOV traded down $0.08 during midday trading on Monday, reaching $4.46. 3,120,886 shares of the company traded hands, compared to its average volume of 6,814,063. Clover Health Investments has a 52 week low of $0.61 and a 52 week high of $4.87. The stock has a 50-day moving average price of $3.83 and a 200 day moving average price of $3.44. The company has a market cap of $2.23 billion, a price-to-earnings ratio of -22.30 and a beta of 1.99.

Analysts Set New Price Targets

Separately, Craig Hallum assumed coverage on shares of Clover Health Investments in a research note on Tuesday, December 17th. They set a “buy” rating and a $6.00 price objective on the stock.

Institutional Investors Weigh In On Clover Health Investments

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Clover Health Investments by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock worth $61,693,000 after acquiring an additional 386,499 shares in the last quarter. Geode Capital Management LLC raised its position in Clover Health Investments by 1.1% in the fourth quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company’s stock worth $15,387,000 after acquiring an additional 53,760 shares in the last quarter. Marshall Wace LLP raised its position in Clover Health Investments by 167.6% in the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock worth $11,875,000 after acquiring an additional 2,360,902 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in Clover Health Investments by 5.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock worth $8,461,000 after acquiring an additional 150,550 shares in the last quarter. Finally, State Street Corp raised its position in Clover Health Investments by 65.0% in the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock worth $6,174,000 after acquiring an additional 862,621 shares in the last quarter. 19.77% of the stock is currently owned by institutional investors.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.